Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues
Product revenue, net	$ 101,847,000	$ 69,228,000	$ 289,102,000	$ 200,889,000
Collaboration revenue	418,000	0	816,000	0
Total revenues	102,265,000	69,228,000	289,918,000	200,889,000
Expenses
Cost of product revenue	(36,569,000)	(25,479,000)	(105,336,000)	(70,579,000)
Cost of collaboration revenue	(348,000)	0	(433,000)	0
Research and development	(65,982,000)	(58,767,000)	(182,252,000)	(183,920,000)
Selling, general, and administrative	(67,219,000)	(68,552,000)	(216,123,000)	(198,982,000)
Gain on sale of intellectual property	0	0	0	10,000,000
Loss from operations	(67,853,000)	(83,570,000)	(214,226,000)	(242,592,000)
Interest income	9,029,000	9,172,000	28,017,000	29,493,000
Interest expense	(745,000)	0	(1,350,000)	0
Foreign currency gains (losses)	14,457,000	4,852,000	8,281,000	(26,315,000)
Other income, net	3,441,000	394,000	3,859,000	223,000
Loss before income tax	(41,671,000)	(69,152,000)	(175,419,000)	(239,191,000)
Income tax expense	0	0	0	0
Net loss	$ (41,671,000)	$ (69,152,000)	$ (175,419,000)	$ (239,191,000)
Loss per share - basic (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.18)	$ (0.25)
Loss per share - diluted (in dollars per share)	$ (0.04)	$ (0.07)	$ (0.18)	$ (0.25)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares)	981,687,390	968,767,730	976,941,030	965,060,570
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares)	981,687,390	968,767,730	976,941,030	965,060,570